The scale may go down, but it doesn’t always stay there. About 1 in 8 American adults now says they’ve used GLP-1 drugs such as Ozempic and Wegovy to lose weight or manage a chronic condition. But many also stop using them — and often regain the weight. “It came back with taxes,” said Pamela … Read more
It’s a battle of the sexes. The diabetes-turned-weight-loss drug Mounjaro has been making headlines for its effectiveness at helping people shed pounds, even delivering better results than Ozempic. And when it comes to who loses more weight on the blockbuster drug, research has found one group comes out on top. It’s a battle of the … Read more
Uncontrollable vomiting. Seizures. Throwing up blood. These are some of the horrifying symptoms people have reported after overdosing on GLP-1 drugs. Though the drugs have been around since 2005 to manage diabetes, they exploded in use after 2021, when Wegovy was approved by the FDA to treat obesity. Since then, GLP-1 use has quadrupled to … Read more
Millions of Medicare patients will be eligible for GLP-1 weight-loss drugs like Ozempic and Wegovy at a cut-rate $50 per month under an upcoming government program. Up to 14 million Medicare recipients are overweight and could qualify for the discounted drug program — known as the Medicare GLP-1 Bridge — which rolls out July 1 … Read more
GLP-1s seem to be fertile ground for a variety of health benefits. Recently, research has suggested the weight loss drugs might also help reduce risk of dementia and depression, help with ADHD symptoms and even reduce risks of breast cancer. Now, new findings suggest GLP-1s — popularly sold under brand names like Ozempic and Mounjaro … Read more
Sometimes, seeing isn’t believing. Across the country, Americans are losing weight faster than ever thanks to blockbuster obesity drugs like Wegovy and Zepbound, with roughly one in eight US adults now turning to GLP-1s to slim down. But for some users, the dramatic physical changes come with an unexpected psychological twist. Users of GLP-1 drugs … Read more
Balding might make you blue — but this news won’t. A recent study suggests that a controversial liquid popular in biohacking and wellness circles could support scalp health and hair growth. Researchers say the substance may even hold promise for GLP-1 users with thinning crowns, a frustrating side effect that’s become increasingly common as the … Read more
Gail Rudnick and Kim Murstein — the no-nonsense hosts of hit podcast series “Excuse My Grandma” — are The Post’s brand-new advice columnists. From family feuds to friendship fallouts, money, marriage and sex, there’s no topic too taboo to tackle, and the native New Yorkers will hash out each issue from their differing perspectives to tell the … Read more
Slimming down on a GLP-1 is one thing — keeping the pounds off after stopping the drug is another. But now, a groundbreaking new study suggests an experimental outpatient procedure may help prevent weight regain in patients no longer using the blockbuster diabetes and obesity meds. “As effective as GLP-1 medications are, many people stop … Read more
The pandemic changed how Americans think about health — and who they trust to manage it. In the wreckage of lockdowns, millions turned away from doctors and toward influencers. Now, a growing number of wellness creators and everyday people are taking their health — and appearance — into their own hands. Literally. Across TikTok, Telegram … Read more
That’s some serious star power! Shortly after his baffling Pizza Hut commercial dropped, ex-NFL star Tom Brady was named chief wellness officer of eMed, a digital health platform for GLP-1 drugs and more. The seven-time Super Bowl champion, 48, joins the ranks of superstar athletes promoting the blockbuster weight loss and diabetes meds, a head-scratching … Read more
Derek Bartel didn’t recognize himself. Looking back at photos from a recent trip, he was convinced his wife had pulled a prank. “Oh my god, is that me?” Bartel, 39, recalled thinking, certain she’d edited the images to make him look wider. “There’s no way I look like that.” But it was him — every shocking, … Read more
Slimmer waist, weaker buzz? A new study suggests GLP-1 drugs like Ozempic and Wegovy — commonly used for diabetes and weight loss — may also blunt the effects of alcohol. That might be bad news for casual drinkers, but scientists at Virginia Tech’s Fralin Biomedical Research Institute said it could open the door to a … Read more